Top-Rated Contemporary Migraine Therapies: A Detailed Overview

Migraine is a debilitating neurological disorder characterized by recurrent episodes of moderate to severe headache accompanied by symptoms such as nausea, photophobia, and phonophobia. Over the years, considerable progress has been made in understanding the pathophysiology of migraine, leading to the development of various treatment modalities. This review provides an overview of the current landscape of migraine therapy, focusing on both established and emerging treatment options. Traditional pharmacological agents, including nonsteroidal anti-inflammatory drugs (NSAIDs), triptans, and preventive medications, are discussed, along with their mechanisms of action, efficacy, and side effect profiles. Additionally, recent advancements in migraine management, particularly the introduction of calcitonin gene-related peptide (CGRP) monoclonal antibodies, are explored. The efficacy, safety, and implications of these novel biologics in clinical practice are reviewed, alongside considerations for personalized treatment approaches and the role of non-pharmacological interventions. Furthermore, challenges such as treatment access, affordability, and long-term safety are addressed, underscoring the need for continued research and interdisciplinary collaboration to optimize outcomes and alleviate the global burden of migraine.